The Archive · 1 posts
Invest in cutting-edge healthcare! 🌟 Hutchmed (China) Limited (HCM) is innovating traditional Chinese medicine and oncology treatments! 🚀
HUTCHMED's 2025 profits hit $457M from a major divestment, while China sales rebound and its novel ATTC cancer platform enters clinical trials.
March 6, 2026
Showing 0 of 1 posts